UK markets closed

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2500+0.0700 (+3.21%)
At close: 04:00PM EDT
2.2200 -0.03 (-1.33%)
After hours: 06:24PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.28-0.26-1.28-2.32
Low estimate-0.28-0.26-1.28-2.32
High estimate-0.28-0.26-1.28-2.32
Year ago EPS-0.28-0.24-1.15-1.28
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.27-0.27-0.26-0.24
Actual EPS-0.28-0.24-0.37-0.28
Difference-0.010.03-0.11-0.04
Surprise %-3.70%11.10%-42.30%-16.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.28-0.26-1.28-2.32
7 days ago-0.2-0.18-0.97-2.3
30 days ago-0.2-0.18-0.97-2.3
60 days ago-0.2-0.2-0.83-1.48
90 days ago-0.2-0.2-0.83-1.48
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesACXPIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.-8.30%N/AN/AN/A
Current year-11.30%N/AN/AN/A
Next year-81.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A